BackgroundBrachytherapy is an important component in management of cervical cancer, enabling dose escalation with reasonable limitation toxicity. However, some patients, there inadvertent increase OAR (Organs at Risk) doses. In our study, we analyse the dosimetric differences between two commonly used ICBT (Intracavitary Brachytherapy) applicators hospital.MethodsWe performed a retrospective an...